This article is more than 5 years old. Information may no longer be current.
Latest in breast cancer screening, prevention for physicians
Click Here to Manage Email Alerts
Approximately one in eight women in the U.S. will develop breast cancer during their lifetime, according to the National Cancer Institute.
Breast cancer risk can be reduced by regular screenings and various prevention strategies.
Marking Breast Cancer Awareness Month, Healio Internal Medicine presents the latest news, research and expert opinion on breast cancer screening and prevention.
Breast cancer risk, breast density useful in guiding mammogram frequency
Tailoring mammography screening intervals to each patient will help in maximizing benefits and minimizing harms, according to findings published in the Annals of Internal Medicine. Read more.
Almost one-third of breast cancer cases traced to modifiable behavior
Recent study data published in JAMA Oncology suggest that 29% of breast cancer cases among white women in the United States could be prevented if women avoided smoking and drinking, did not use any menopausal hormones and maintained a lean body mass. Read more.
Physicians should motivate hospitalized women at risk for breast cancer to be screened
A researcher identified several predictors of nonadherence to breast cancer screenings among hospitalized women, according to findings presented at the Society of Hospital Medicine Annual Meeting. Read more.
USPSTF breast cancer screening recommendations ‘very similar’ to previous advice
The U.S. Preventive Services Task Force’s recent recommendation statement on breast cancer screening mammography is quite similar to the organization’s last recommendation statement in 2009, according to Haydee Ojeda-Fournier, MD, medical director of breast imaging at the University of California, San Diego. Read more.
American Cancer Society's recommendations on breast cancer screening
The American Cancer Society recommends screening for breast cancer beginning at age 45 years, although women aged 40 to 44 should have flexibility in starting annual screenings, Kevin C. Oeffinger, MD, director of the Cancer Survivorship Center at Memorial Sloan Kettering, in New York, said at the American College of Physicians Internal Medicine Meeting. Read more.
Guideline revisions dramatically change approaches to breast cancer screening
Clinicians should consider a woman’s overall risk for developing breast cancer when establishing screening protocols, Melissa McNeil, MD, MPH, MACP, Chief of the Section on Women’s Health at the University of Pittsburgh Medical Center, said at the ACP Internal Medicine Meeting. Read more.
ACP recommends less cancer screening for average-risk adults
The ACP released clinical guidelines for screening average-risk adults without symptoms for several common cancers. Read more.
Clinical, self-exam may be viable breast screening options in resource-limited settings
Holly Pederson, MD, director of Medical Breast Services in the Breast Center at Cleveland Clinic, highlighted early findings from a study that found that intensive intervention with clinical breast exam and self-exam yielded a significant downstaging of cancers compared with no intervention. The results suggest these exams “may actually be useful after all,” Pederson told HemOnc Today. Read more.
Benefits of tamoxifen for breast cancer prevention vary among at-risk women
Although most women who use tamoxifen for breast cancer prevention will derive benefit, more attention must be paid to the risk–benefit profiles of certain subgroups of at-risk women who may be more likely to experience serious side effects, according to study results. Read more.
What cancer screenings are recommended for women?
Women have a 37% chance of developing invasive cancer during their lifetime, and a 19% chance of dying of cancer, according to American Cancer Society statistics. Early detection dramatically increases the potential for treatment success, illustrating the importance of routine screenings that can detect cancer prior to symptom onset. Read more.